Prevalence, Incidence and Mortality of Thyroid Cancer in Kazakhstan: Data from the Unified National Electronic Health System 2014-2021

2026

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.63946/ehdi/17889
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Introduction: Thyroid cancer is one of the most common endocrine malignancies. According to global studies, its prevalence has been increasing worldwide and continues to grow. Although there have been global epidemiological studies on thyroid cancer, there is limited data on its epidemiology in Central Asian countries, including Kazakhstan. Materials and Methods: A retrospective study utilized data from the Unified National Electronic Health System on thyroid cancer patients in Kazakhstan from 2014 to 2021. A descriptive analysis of patients was performed based on key demographic factors. Survival analysis was conducted using the Kaplan-Meier estimator and Cox proportional hazards regression. Results: In total, 4,877 cases of thyroid cancer have been included during the period from 2014 to 2021 in Kazakhstan. Most of the diagnosed patients throughout the given period were females. The highest incidence and prevalence rates were found in the age group of 51-70 years old, while the highest mortality rate was among patients older than 70 years. Increasing age and male sex were the major predictors of mortality among thyroid cancer patients. Conclusion: The obtained data coaligned with global data on thyroid cancer. Increased age, male sex, and living area were associated with poor prognosis. The study was limited by missing information on comorbidities and treatment types that the patients could have received. Therefore, further research is needed to assess the impact of such significant factors on survival.